Skip to main content
. 2022 Nov 23;60(1):2295–2299. doi: 10.1080/13880209.2022.2147550

Table 3.

Distribution of concomitant treatments (N = 232 patients).

Type of treatment Baseline* (N = 232)
Number (%)
6-week (N = 230) Number (%) 3-month (N = 218) Number (%) p-Value
NSAIDS 128 (55.2) 64 (27.8) 46 (21.1) <0.0001
Pain killers 150 (64.7) 115 (50.0) 91 (41.7) 0.083
Topical 71 (30.6) 30 (13.0) 15 (6.9) <0.0001
Others 17 (7.3) 11 (4.8) 10 (4.6)  

*Reported in patient history.